$44.84
3.71% yesterday
Nasdaq, May 20, 09:01 pm CET
ISIN
US74265M2052
Symbol
PDEX

Pro-Dex, Inc. Stock price

$44.57
-13.74 23.56% 1M
-3.06 6.42% 6M
-2.18 4.66% YTD
+25.27 130.93% 1Y
+29.50 195.75% 3Y
+25.86 138.21% 5Y
+42.27 1,838.08% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.34 3.10%
ISIN
US74265M2052
Symbol
PDEX
Sector

Key metrics

Market capitalization $145.34m
Enterprise Value $155.04m
P/E (TTM) P/E ratio 15.93
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.42
P/S ratio (TTM) P/S ratio 2.27
P/B ratio (TTM) P/B ratio 4.12
Revenue growth (TTM) Revenue growth 29.65%
Revenue (TTM) Revenue $64.12m
EBIT (operating result TTM) EBIT $11.70m
Free Cash Flow (TTM) Free Cash Flow $-1.75m
Cash position $9.89m
EPS (TTM) EPS $2.80
P/S forward 2.14
EV/Sales forward 2.28
Short interest 37.27%
Show more

Is Pro-Dex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Pro-Dex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pro-Dex, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Pro-Dex, Inc.:

Buy
100%

Financial data from Pro-Dex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
64 64
30% 30%
100%
- Direct Costs 44 44
23% 23%
68%
21 21
45% 45%
32%
- Selling and Administrative Expenses 4.05 4.05
14% 14%
6%
- Research and Development Expense 3.57 3.57
17% 17%
6%
13 13
71% 71%
20%
- Depreciation and Amortization 1.23 1.23
10% 10%
2%
EBIT (Operating Income) EBIT 12 12
82% 82%
18%
Net Profit 9.37 9.37
115% 115%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Pro-Dex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pro-Dex, Inc. Stock News

Positive
Seeking Alpha
16 days ago
Pro-Dex, Inc. experienced a 32% stock crash despite record Q3 2025 performance, presenting a buying opportunity for risk-tolerant investors. Q3 2025 revenue grew 22% YoY, with gross profit up 45% due to favorable product mix; operating income increased 64%. PDEX's PEG ratio of 0.27x indicates undervaluation compared to sector median, despite higher valuation multiples in other metrics.
Neutral
Accesswire
19 days ago
IRVINE, CA / ACCESS Newswire / May 1, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 third quarter ended March 31, 2025.
Positive
Seeking Alpha
4 months ago
In 4Q24, we crossed $10M in AUM, emphasizing patient growth and strategic portfolio management, with a focus on long-term investments and five-year doubles. Key drivers include CCRD, PDEX, and RSSS, with CoreCard benefiting from a new contract with Goldman, and Pro-Dex showing strong business performance. Matrix Service is expected to convert backlog to profit in the next 18-24 months, while ne...
More Pro-Dex, Inc. News

Company Profile

Pro-Dex, Inc. engages in the design, development, and manufacture of rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. It specializes in medical device and services, industrial and scientific, dental and component, repairs, and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding, and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Head office United States
CEO Richard Kirk
Employees 148
Founded 1994
Website www.pro-dex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today